Healthcare at a Crossroads: Why market research matters more than ever

Healthcare is undergoing a period of profound change, driven by evolving government policy, increasing financial pressures, technological innovation and changing patient expectations.

In the UK, the NHS 10 Year Health Plan signals a significant shift towards prevention, community-based care and digital transformation. At the same time, artificial intelligence (AI) is opening up new possibilities for diagnosis, treatment and healthcare delivery.

Alongside these developments, we are seeing an increasingly complex relationship between publicly funded healthcare and private sector provision. As patients explore different routes to accessing treatment, and private providers, insurers and digital health companies expand their offerings, the traditional boundaries of healthcare are becoming less distinct.

For organisations operating in this changing environment, understanding how people think, feel and make decisions about healthcare has arguably never been more important. This is where market research, and particularly qualitative research and focus groups, has a critical role to play.

Private healthcare is no longer necessarily viewed solely as an alternative to the NHS. Increasingly, patients may combine NHS treatment with privately funded consultations, diagnostic services, digital health platforms or employer-supported healthcare. This emerging hybrid model creates opportunities for providers to develop services that complement existing healthcare pathways.

However, it also introduces important questions about patient behaviour, trust, affordability and expectations. What motivates someone to pay privately for a consultation or diagnostic test? Is speed of access the primary consideration, or are factors such as convenience, continuity of care and perceived quality equally important?

How do patients feel about private organisations delivering services on behalf of the NHS? And how does willingness to pay differ between demographic groups, health conditions and stages of life?

These questions are commercially significant, but they also have wider implications for healthcare access and equity. Market research can help providers understand where genuine unmet needs exist, which services patients value and how different models of healthcare provision are perceived. Without this insight, organisations risk developing propositions based on assumptions about what patients want rather than evidence of what they actually need.

AI and the importance of trust

Artificial intelligence represents another major transformation in healthcare. From diagnostic imaging and clinical decision support to remote monitoring and administrative processes, AI has the potential to improve efficiency and reshape the patient experience.

The government’s healthcare strategy places significant emphasis on the adoption of AI and other digital technologies across the NHS. Yet technological innovation alone does not guarantee acceptance.

Patients may welcome faster diagnoses but feel uncomfortable about the role of algorithms in clinical decisions. Healthcare professionals may recognise the benefits of AI while questioning its reliability, accountability or impact on clinical autonomy.

For technology developers and healthcare providers, understanding these concerns is essential. Focus groups can explore how patients respond to AI-enabled services, the language used to explain them and the level of human involvement they expect. Research can also identify differences between what people initially say about AI and how their attitudes develop when presented with practical examples.

Ultimately, successful adoption depends not simply on what technology can deliver, but on whether people understand and trust it.

Why research needs to happen earlier

One of the greatest risks in a rapidly changing healthcare market is that organisations develop products, services or strategies before fully understanding their intended audiences.

This is particularly relevant as private providers explore new models of care, insurers develop additional benefits and digital health businesses seek to establish themselves within increasingly competitive markets. Market research should not simply be used to validate decisions already made.

It should help shape those decisions from the outset. Early-stage qualitative research can identify unmet needs, explore patient journeys and challenge assumptions about demand.

Focus groups can test service concepts, pricing perceptions, communication strategies and potential barriers before significant investment is committed. Quantitative research can then help establish the size of opportunities, identify relevant patient segments and support commercial decision-making. This combination becomes especially valuable when organisations are navigating uncertain policy environments and rapidly changing consumer expectations.

Keeping the human perspective central

As healthcare becomes increasingly data-driven, it is tempting to assume that advances in analytics and AI will reduce the need for traditional research methods. In reality, the opposite may be true. Data can identify patterns in behaviour, but it does not always explain the motivations behind them.

It may show that patients are choosing private diagnostic services, but not fully reveal whether those choices reflect convenience, anxiety, dissatisfaction or a lack of alternatives. It may highlight low adoption of a digital healthcare platform without explaining whether the underlying problem is usability, accessibility or trust.

Qualitative research helps provide this missing context. At Bryter, we recognise the importance of combining rigorous research methodologies with a genuine understanding of the people behind the data. As healthcare continues to evolve, organisations will need insights that are not only reliable but capable of informing practical, commercially relevant decisions.

Looking ahead

The future of healthcare is likely to involve a more interconnected mix of public and private provision, greater digital engagement and an expanding role for AI. These changes offer significant opportunities to improve access, patient experience and healthcare outcomes.

Yet they also create uncertainty for patients, providers, policymakers and businesses. Those organisations that succeed will be the ones that understand changing expectations, recognise emerging barriers and adapt their services accordingly. Market research and focus groups should therefore be viewed not as optional stages in product development, but as essential components of healthcare strategy.

In a landscape increasingly shaped by policy reform, private sector innovation and technological change, listening to patients and healthcare professionals is not simply good research practice. It is fundamental to making better healthcare decisions.